New research suggests that curcumin, a component of the Indian spice turmeric, may help maintain the effectiveness of a drug used to treat cancers of the head and neck. Although such cancers usually respond to cisplatin at first, they often develop resistance. Research in tissue cultures found that a compound derived from curcumin can reduce or overcome that resistance. The compound is called FLLL32, and it is not yet available for clinical use. The compound affects a protein called STAT3 that is overactive in many of these cancers. The researchers hope to develop a form of FLLL32 that can be taken by cancer patients.
[Archives of Otolaryngology – Head and Neck Surgery, May, 2011]

Join Over 68,000 Subscribers at The People's Pharmacy

Each week we send two free email newsletters with breaking health news, prescription drug information, home remedies and a preview of our award-winning radio show. Join our mailing list and get the information you need to make confident choices about your health.

  1. Dave
    Reply

    I listened with interest (7/16/11) about the segment on curcumin/turmeric. According to Dr. Servan-Schreiber’s book, AntiCancer, page 105, “…pepper multiplies the body’s absorption of turmeric by two thousand. Indian wisdom has thus been far ahead of modern science in the discovery of natural affinities between foods.”

  2. Paul43
    Reply

    What is cisplatin?
    PEOPLE’S PHARMACY RESPONSE: THIS IS A POWERFUL ANTI-CANCER DRUG.

What Do You Think?

We invite you to share your thoughts with others, but remember that our comment section is a public forum. Please do not use your full first and last name if you want to keep details of your medical history anonymous. A first name and last initial or a pseudonym is acceptable. Advice from other commenters on this website is not a substitute for medical attention. Do not stop any medicine without checking with the prescriber. Stopping medication suddenly could result in serious harm. We expect comments to be civil in tone and language. By commenting, you agree to abide by our commenting policy and website terms & conditions. Comments that do not follow these policies will not be posted.